TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
GERN

Geron Corporation

Healthcare · Biotechnology

1.30$ -1.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Geron Corporation (GERN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 519 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GERN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
413 394 482 449 445 594 562 555 567 571 534 519
335 341 452 373 398 491 496 506 522 520 499 486
31 71 190 117 60 79 84 78 78 79 71 63
314 335 443 363 340 407 397 388 381 360 314 301
15 1.7 1.6 3.1 30 39 34 39 35 39 44 54
0.5 0.0 0.8 20 39 56 69 95 117 133 124
4.9
122 146 137 143 153 313 294 296 319 345 305 300
89 108 123 104 138 88 63 64 88 112 74 70
23 48 72 48 73 1.0 1.0 1.0 1.0 19 20 1.0
14 6.2 10.0 5.6 14 8.6 8.0 8.2 11 11 13 8.8
30 35 11 37 12 118 119 119 119 120 120 120
291 248 345 307 292 280 268 260 249 226 229 219
-1,546 -1,598 -1,653 -1,721 -1,747 -1,772 -1,792 -1,809 -1,827 -1,856 -1,859 -1,876
580 595 603 654 662 646 666 666 667 667 669 671

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?